Complementary and alternative medicine in the treatment of prostate cancer

Journal of Men's Health and Gender

Volumn 3, Issue 4, 2006, Pages 397-403

  Auerbach, Leo ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Antioxidants; CAM; Phytoestrogens; Prostate cancer; Quality of life

Indexed keywords

ALPHA 2 MACROGLOBULIN; ALPHA TOCOPHEROL; ALPHA TOCOTRIENOL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; BETA TOCOPHEROL; CAROTENOID; DELTA TOCOPHEROL; GAMMA TOCOPHEROL; GAMMA TOCOTRIENOL; GENISTIN; HERBACEOUS AGENT; ISOFLAVONE; LYCOPENE; PC SPES; PHYTOESTROGEN; RETINOL; SELENIUM; VISCUM ALBUM LECTIN;

ALTERNATIVE MEDICINE; ANTIOXIDANT ACTIVITY; ARTICLE; BREAST HYPERTROPHY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DRUG MECHANISM; ENZYME THERAPY; HERBAL MEDICINE; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; NONHUMAN; PHYSIOTHERAPY; PRIORITY JOURNAL; PROSTATE CANCER; PSYCHOTHERAPY; QUALITY OF LIFE; RELAXATION TRAINING; TREATMENT CONTRAINDICATION; VISCUM ALBUM;

EID: 33750796127     PISSN: 15718913     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmhg.2006.10.006     Document Type: Article

References (53)

1. Cassileth B.R., and Deng G. Complementary and alternative therapies for cancer. Oncologist 9 (2004) 80-89
2. Beuth J., and Uhlenbruck G. Evidenzbasierte komplementäre Therapiemassnahmen beim Prostatakarzinom. Deutsche Zeitschrift für Onkologie 34 (2002) 86-90
3. Dreikorn K. Complementary and alternative medicine in urology. BJU Int 96 (2005) 1177-1184
4. Fair W.R. Back to the future - the role of complementary medicine in urology. J Urol 162 (1999) 411-420
5. Moyad M.A. Selenium and vitamin E supplements for prostate cancer: evidence or embellishment?. Urology 59 (2002) 9-19
6. Chan J.M., Stampfer M.J., Ma J., Rimm E.B., Willett W.C., and Giovannucci E.L. Supplemental vitamin E intake and prostate cancer risk in a large cohort of men in the United States. Cancer Epidemiol Biomarkers Prev 8 (1999) 893-899
7. Heinonen O.P., Albanes D., Virtamo J., et al. Prostate cancer and supplementation with α-tocopherol and β-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst 90 (1998) 440-446
8. Omenn G.S., Goodman G.E., Thornquist M.D., et al. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst 88 (1996) 1550-1559
9. Hennekens C.H., Buring J.E., Manson J.E., et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 334 (1996) 1145-1149
10. Stahl W., Nicolai S., Briviba K., et al. Biological activities of natural and synthetic carotenoids: induction of gap junctional communication and singlet oxygen quenching. Carcinogenesis 18 (1997) 89-92
11. Mettlin C., Selenskas S., Natarajan N., et al. Beta-carotene and animal fats and their relationship to prostate cancer risk: a case-control study. Cancer 64 (1989) 605-612
12. Le Marchand L., Hankin J.H., Kolonel L.N., et al. Vegetable and fruit consumption in relation to prostate cancer risk in Hawaii: a reevaluation of the effect of dietary beta-carotene. Am J Epidemiol 133 (1991) 215-219
13. Key T.J., Silcocks P.B., Davey G.K., et al. A case-control study of diet and prostate cancer. Br J Cancer 76 (1997) 678-687
14. Tzonou A., Signorello L.B., Lagiou P., et al. Diet and cancer of the prostate: a case-control study in Greece. Int J Cancer 80 (1999) 704-708
15. Norrish A.E., Jackson R.T., Sharpe S.J., et al. Prostate cancer and dietary carotenoids. Am J Epidemiol 151 (2000) 119-123
16. Giovannucci E., Rimm E.B., Liu Y., et al. A prospective study of tomato products, lycopene, and prostate cancer risk. J Natl Cancer Inst 94 (2002) 391-398
17. Wilkinson S., and Chodak G.W. Critical review of complementary therapies for prostate cancer. J Clin Oncol 21 11 (2003) 2199-2210
18. Zhang Y., Ni J., Messing E.M., Chang E., Yang C.R., and Yeh S. Vitamin E succinate inhibits the function of androgen receptor and the expression of prostate-specific antigen in prostate cancer cells. Proc Natl Acad Sci USA 99 (2002) 7408-7413
19. Nelson P.S., and Montgomery B. Unconventional therapy for prostate cancer: good, bad or questionable?. Nature review cancer 3 (2003) 845-858
20. Gann P.H., Ma J., Giovannucci E., et al. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res 59 (1999) 1225-1230
21. Dong Y., Zhang H., Hawthorn L., Ganther H.E., and Ip C. Delineation of the molecular basis for selenium-induced growth arrest in human prostate cancer cells by oligonucleotide array. Cancer Res 63 (2003) 52-59
22. Duffield-Lillico A.J., Reid M.E., Turnbull B.W., et al. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers Prev 11 (2002) 630-639
23. Webber M.M., Perez-Ripoll E.A., and James G.T. Inhibitory effects of selenium on the growth of DU-145 human prostate carcinoma cells in vitro. Biochem Biophys Res Commun 130 (1985) 603-609
24. Menter D.G., Sabichi A.L., and Lippman S.M. Selenium effects on prostate cell growth. Cancer Epidemiol Biomarkers Prev 9 (2000) 1171-1182
25. Zhong W., and Oberley T.D. Redox-mediated effects of selenium on apoptosis and cell cycle in the LNCaP human prostate cancer cell line. Cancer Res 61 (2001) 7071-7078
26. Redman C., Scott J.A., Baines A.T., et al. Inhibitory effect of selenomethionine on the growth of three selected human tumor cell lines. Cancer Lett 125 (1998) 103-110
27. Venkateswaran V., Klotz L.H., and Fleshner N.E. Selenium modulation of cell proliferation and cell cycle biomarkers in human prostate carcinoma cell lines. Cancer Res 62 (2002) 2540-2545
28. Clark L.C., Combs Jr. G.F., Turnbull B.W., et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 276 (1996) 1957-1963
29. Moyad M.A. Selenium and vitamin E supplements for prostate cancer: evidence or embellishment?. Urology 59 4 Suppl 1 (2002) 9-19
30. Adlercreutz C.H., Goldin B.R., Gorbach S.L., et al. Soybean phytoestrogen intake and cancer risk. J Nutr 125 suppl 3 (1995) 757S-770S
31. Evans B.A., Griffiths K., and Morton M.S. Inhibition of 5 alpha-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J Endocrinol 147 (1995) 295-302
32. Shen J.C., Klein R.D., Wei Q., et al. Low-dose genistein induces cyclin-dependent kinase inhibitors and G1 cell-cycle arrest in human prostate cancer cells. Mol Carcinog 29 (2000) 92-102
33. Geller J., Sionit L., Partido C., et al. Genistein inhibits the growth of human-patient BPH and prostate cancer in histoculture. Prostate 34 (1998) 75-79
34. Santibanez J.F., Navarro A., and Martinez J. Genistein inhibits proliferation and in vitro invasive potential of human prostatic cancer cell lines. Anticancer Res 17 (1997) 1199-1204
35. Fotsis T., Pepper M., Adlercreutz H., et al. Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci USA 90 (1993) 2690-2694
36. Pollard M., and Wolter W. Prevention of spontaneous prostate-related cancer in Lobund-Wistar rats by a soy protein isolate/isoflavone diet. Prostate 45 (2000) 101-105
37. Pollard M., and Luckert P.H. Influence of isoflavones in soy protein isolates on development of induced prostate-related cancers in L-W rats. Nutr Cancer 28 (1997) 41-45
38. Bylund A., Zhang J.X., Bergh A., et al. Rye bran and soy protein delay growth and increase apoptosis of human LNCaP prostate adenocarcinoma in nude mice. Prostate 42 (2000) 304-314
39. Zhou J.R., Gugger E.T., Tanaka T., et al. Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice. J Nutr 129 (1999) 1628-1635
40. Fritz W.A., Wang J., Eltoum I.E., et al. Dietary genistein down-regulates androgen and estrogen receptor expression in the rat prostate. Mol Cell Endocrinol 186 (2002) 89-99
41. Messina M.J., Persky V., Setchell K.D., et al. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer 21 (1994) 113-131
42. Kolonel L.N., Hankin J.H., Whittemore A.S., et al. Vegetables, fruits, legumes and prostate cancer: a multiethnic case-control study. Cancer Epidemiol Biomarkers Prev 9 (2000) 795-804
43. Strom S.S., Yamamura Y., Duphorne C.M., et al. Phytoestrogen intake and prostate cancer: a case-control study using a new database. Nutr Cancer 33 (1999) 20-25
44. Jacobsen B.K., Knutsen S.F., and Fraser G.E. Does high soy milk intake reduce prostate cancer incidence? The Adventist Health Study (United States). Cancer Causes Control 9 (1998) 553-557
45. Bosland M.C., Kato I., Melamed J., et al. Chemoprevention trials in men with prostate-specific antigen failure or at high risk for recurrence after radical prostatectomy: application to efficacy assessment of soy protein. Urology 57 suppl 1 (2001) 202-204
46. DiPaola R.S., Zhang H., Lambert G.H., et al. Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer. N Engl J Med 339 (1998) 785-791
47. Kubota T., Hisatake J., Hisatake Y., et al. PC-SPES: a unique inhibitor of proliferation of prostate cancer cells in vitro and in vivo. Prostate 42 (2000) 163-171
48. de le Taille A., Buttyan R., Hayek O., et al. Herbal therapy PC-SPES: in vitro effects and evaluation of its efficacy in 69 patients with prostate cancer. J Urol 164 (2000) 1229-1234
49. Hsieh T.C., and Wu J.M. Mechanism of action of herbal supplement PC-SPES: elucidation of effects of individual herbs of PC-SPES on proliferation and prostate specific gene expression in androgen-dependent LNCaP cells. Int J Oncol 20 (2002) 583-588
50. Small E.J., Frohlich M.W., Bok R., et al. Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer. J Clin Oncol 18 (2000) 3595-3603
51. Pfeifer B.L., Pirani J.F., Hamann S.R., et al. PC-SPES, a dietary supplement for the treatment of hormone-refractory prostate cancer. BJU Int 85 (2000) 481-485
52. Sovak M., Seligson A.L., Konas M., et al. Herbal composition PC-SPES for management of prostate cancer: identification of active principles. J Natl Cancer Inst 94 (2002) 1275-1281
53. Dreikorn K. Complementary and alternative medicine in urology. BJU Int 96 (2005) 1177-1184